Plasma antioxidative activity in patients treated with fluvastatin and fenofibrate;Aktywność antyoksydacyjna osocza u osób leczonych fluwastatyna i fenofibratem

Polski Przeglad Kardiologiczny

Volumn 5, Issue 2, 2003, Pages 185-189

  Kowalski, Jan ^a   Olejniczak, Jarosław ^a   Bartosz, Grzegorz ^b   Pawlicki, Lucjan ^a   Gburek, Jolanta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Katedra Biofizyki Molekularnej UM ^*  (Poland)

Author keywords

Fenofibrate; Fluvastatin; Plasma antioxidative activity; Stable angina pectoris

Indexed keywords

FENOFIBRATE; FLUINDOSTATIN; FREE RADICAL; LIPID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MEDICAL ASSESSMENT; PATIENT CARE; SPECTROPHOTOMETRY; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

EID: 0038466116     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Esterbauer H., Wäg G., Puhl H.: Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull., 1993, 49, 566-576.
2. Halliwell B.: How to characterize a biological antioxidant. Free Radic. Res. Comm., 1990, 9, 1-32.
3. Basage H.S.: Biochemical aspects of free radicals. Biochem. Cell. Biol., 1990, 68, 989-998.
4. Pawlicki L., Kowalski J.: Rola metabolizmu tlenowego i granulocytów w niedokrwienno-reperfuzyjnym uszkodzeniu serca. Postepy Nauk Med., 1994, 7, 77-81.
5. Bednarska-Makaruk M., Pasierski T.: Pozalipidowe (pleotropowe) działanie statyn. [w:] M. Bednarska-Makaruk, T. Pasierski (red.): Statyny. Wydawnictwo Medycyna Praktyczna, Kraków 2000, 71.
6. Bartosz G., Janaszewska A., Ertel D.: Spectrophotometric determination of peroxyl radical-trapping capacity with ABAP and ABTS. Curr. Top. Biophys., 1998, 22, supl. B, 11-13.
7. Janssen M., Vandermeer P., Dejong J.W.: Antioxidant defences in rat, pig, guinea pig and human hearts - comparison with xanthine oxidoreductase activity. Cardiovasc. Res., 1993, 27, 2052-2057.
8. Bendich A.: Exercise and free radicals: effects of antioxidant vitamins. Med. Sport Sci., 1991, 32, 59-64.
9. Frei B., Stocker R., Ames B.N. i wsp.: Antioxidant defences and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. (USA), 1988, 85, 9748-9752.
10. Bartosz G.: Druga twarz tlenu. Wydawnictwo PWN, Warszawa 1995.
11. Retsky K.L., Freeman M.W., Rei B.: Ascorbic acid oxidation products protect human low density lipoprotein against atherogenic modification. J. Biol. Chem., 1993, 268, 1304-1309.
12. Kaul N., Siveski-Jiskovic N.: Free radicals and heart. J. Pharmacol. Toxicol. Methods., 1993, 30, 55-67.
13. Canfield L.M., Farago J.W., Valenzuche J.G.: Carotenoides as cellular antioksidants. Proc. Soc. Exp. Biol. Med., 1992, 200, 260-265.
14. Tubaro F., Chiselli A., Rapuzzi P. i wsp.: Analysis of plasma antioxidant capacity by competition kinetics. Free Radic. Biol. Med., 1998, 24, 1228-1234.
15. Salonen R., Nyyssonen K., Porkkala-Sarataho E. i wsp.: The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am. J. Cardiol., 1995, 76, 34C-39C.
16. Watts G. F., Castelluccio C., Rice-Evans C. i wsp.: Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin. J. Clin. Pathol., 1993, 46, 1055-1057.
17. Laaksonen R., Jokelainen K., Laakso J. i wsp.: The effect of siwvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am. J. Cardiol., 1996, 77, 851-854.
18. Willis R.A., Folkers K., Tucker J.L. i wsp.: Lovastatin decreases coenzyme Q levels in rats. Proc. Natl. Acad. Sci. (USA), 1990, 87, 8928-8930.
19. Marinari U.M., Pronzato M.A., Dapino D. i wsp.: Effects of simvastatin on liver and plasma levels of cholesterol, dolichol and ubiquinol in hypercholesterolemic rats. Ital. J. Biochem., 1995, 44, 1-9.
20. Dujorne C.A.: New lipid lowering drugs and new effects of old drugs. Curr. Opin. Lipidol., 1997, 8, 362-368.